The author provides a list of 33 stocks with bullish outlooks for 2026, citing various catalysts such as AI integration, earnings growth, and valuation resets.
ACN — LONG Accenture is leveraging AI to drive a 10% year-over-year increase in managed services. Improved operating margins are expected by fiscal 2026, supported by positive technical momentum.
Accenture is making strong progress with AI, showing a 10% year-over-year increase in managed services and better operating margins expected in fiscal 2026.
ADP — LONG ADP is a consistent performer with steady earnings and dividend growth. Recent market dips provide an attractive entry point for projected 31% total returns by 2026.
ADP is a reliable performer with consistent earnings and dividends, setting up for about 31% total returns in 2026 due to steady growth and an attractive entry point from recent market dips.
AJG — LONG Arthur J. Gallagher is expanding through acquisitions and organic growth. Analysts expect earnings beats in the near term, supported by a favorable outlook.
Gallagher continues to grow through acquisitions, with organic expansion and likely earnings beats ahead.
BIIB — LONG Biogen's pipeline is advancing, notably with EU approval for a high-dose version of Spinraza. Stable earnings and recent stock performance suggest recovery potential.
Biogen’s pipeline is advancing, including EU approval for a high-dose version of Spinraza, which strengthens the positive outlook.
BRO — LONG Brown & Brown is achieving steady organic growth bolstered by a new healthcare platform. A recent dividend increase further supports the positive investment case.
Brown & Brown maintains steady organic growth, enhanced by a new healthcare platform and a recent dividend increase.
CHDN — LONG Churchill Downs benefits from a strong brand and luxury investments like Derby suites. Significant share buybacks and new track developments are expected to drive higher valuations.
Churchill Downs benefits from its strong brand and investments in luxury experiences like Derby suites, along with share buybacks that have reduced outstanding shares by 30% over the past decade.
CLX — LONG Clorox is trading at an attractive valuation of 16 times forward earnings. Consistent demand for household essentials and high return on invested capital support a recovery.
Clorox is trading at an attractive 16 times forward earnings, given its over 35% return on invested capital.
CMG — LONG Chipotle's long-term growth potential remains intact despite temporary traffic issues. A reset in valuation provides an opportunity to buy into its strong operations.
Chipotle’s long-term potential remains clear despite economic challenges, with strong operations and a reset in valuation creating an opportunity to buy.
CNC — LONG Centene is undervalued with stable earnings and potential to trade at 14 times 2026 EPS. Margin improvements could shift sentiment, though government-related risks persist.
Centene appears undervalued at current multiples, with stable earnings and the possibility of trading at 14 times 2026 earnings per share.
CPRT — LONG Copart maintains a leading position in global auctions with high liquidity and margins. Careful cash management supports a sustainable growth outlook.
Copart holds a leading position in global auctions with over 300,000 buyers ensuring strong liquidity advantages, high margins, and sustainable growth.